An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed Conditions

Clinical trial NCT02722239 · COMPLETED

Trial details

NCT number

NCT02722239

Sponsor

AstraZeneca

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2016-03-30

Primary completion

2016-05-05

Enrollment

40

View on ClinicalTrials.gov